Christopher D. Thibodeau

Chief Operating Officer at OncoCell MDx

Christopher D. Thibodeau

Christopher D. Thibodeau

Chief Operating Officer at OncoCell MDx

Overview
Career Highlights

OncoCell MDx
MDxHealth SA

RelSci Relationships

83

Birthday

1972

Age

47

Contact Data
Trying to get in touch with Christopher D. Thibodeau? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Christopher D. Thibodeau likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Novigenix SA

Relationship likelihood: Strong

President & Chief Executive Officer at OncoCell MDx

Relationship likelihood: Strong

Chief Compliance Officer, Executive Vice President & General Counsel at MDxHealth SA

Relationship likelihood: Strong

Chief Financial Officer at LineaGen, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Executive Vice President at MDxHealth SA

Relationship likelihood: Average

Former Chief Financial Officer & Executive Vice President at MDxHealth SA

Relationship likelihood: Average

Director-Northwest Prostate Institute at Northwest Hospital & Medical Center

Relationship likelihood: Average

Chief Executive Officer at MDxHealth SA

Relationship likelihood: Average

Chief Integration Officer at CoAdvantage Corp.

Relationship likelihood: Average

Senior Director European Commercial Operations, Germany-Selectmdx at MDxHealth SA

Relationship likelihood: Average

Paths to Christopher D. Thibodeau
Potential Connections via
Relationship Science
You
Christopher D. Thibodeau
Chief Operating Officer at OncoCell MDx
Education
Career History
Chief Operating Officer
2019 - Current
Executive Vice President & Chief Operations Officer
2010 - 2019

MDxHealth SA is a molecular diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.

Vice President-Sales & Marketing
2007 - Prior

Numira, Inc. develops and provides molecular imaging technologies for scientific discovery and drug development. Its products include AltaBlu Prime, AltaNexus and AltaViewer. The firm operates as a contract research organization, which provides imaging services for disease research, drug discovery, and pre-clinical studies in animal models. The company services include 3D oncology cell screening, histology, image analysis and imaging. Its therapeutic areas such as CNS, bone, pulmonary, oncology, and inflammation provide extensive value for many researchers. Through the combination of novel software technologies and imaging capabilities, Numira provides clients with an unmatched array of pre-clinical services for research programs in inflammation, cardiovascular, oncology, pulmonary, renal, bone, and other therapeutic areas. Numira was founded in 2005 by Michael A. Beeuwsaert and Charles Keller and is headquartered in Salt Lake, UT.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Christopher D. Thibodeau. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Christopher D. Thibodeau's profile does not indicate a business or promotional relationship of any kind between RelSci and Christopher D. Thibodeau.